Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 10:32 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2185–2208 of 6,034 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Obesity Clear all

Conditions: Obesity (BMI>30), Insulin Resistance
Interventions: human insulin; Drug
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 18 Years to 65 Years
Enrollment: 64 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2032
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Sleep Apnea Syndromes, Inflammation
Interventions: Weight Loss Program, CPAP therapy; Behavioral · Device
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 80 Years
Enrollment: 181 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2013
U.S. locations: 2
States / cities: Philadelphia, Pennsylvania

Conditions: Obesity
Interventions: No intervention; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 91 Years
Enrollment: 303 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Overweight and Obesity
Interventions: Not listed
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 60 Years
Enrollment: 139 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Obesity
Interventions: Leu Sil 1.0mg, Leu Sil 4.0mg, Leu Met Sil 1.0mg, Leu Met Sil 4.0mg, Placebo; Drug
Lead sponsor: NuSirt Biopharma; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 267 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 15
States / cities: Mobile, Alabama • Montclair, California • Sacramento, California + 12 more

Conditions: Obesity, Diabetes Mellitus, Type 2, NAFLD
Interventions: Not listed
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years to 70 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Obesity, Activity, Motor, Diet, Healthy, Sedentary Behavior
Interventions: Healthy Juntos; Behavioral
Lead sponsor: University of Miami; Other
Eligibility: 12 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Obesity
Interventions: Behavioral treatment for childhood obesity; Behavioral
Lead sponsor: University of Minnesota; Other
Eligibility: 8 Years to 12 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Breast Cancer, Obesity, Hypovitaminosis D
Interventions: Vitamin D, Placebo; Dietary Supplement
Lead sponsor: Fred Hutchinson Cancer Center; Other
Eligibility: 50 Years to 75 Years · Female only
Enrollment: 218 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Obesity, NAFLD
Interventions: methyl-D9-choline; Drug
Lead sponsor: Vanderbilt University; Other
Eligibility: 30 Years to 60 Years · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Obese, Elevated Blood Pressure
Interventions: Mat Pilates training; Behavioral
Lead sponsor: Marymount University; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Pediatric Obesity, Health Behavior, Risky
Interventions: Growing Healthy Children and Families in Rural Arkansas; Behavioral
Lead sponsor: University of Arkansas; Other
Eligibility: 7 Years and older
Enrollment: 64 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Obesity
Interventions: Weight-loss and weight-maintenance diets; Behavioral
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 18 Years to 75 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Obesity
Interventions: Behavioral Skills Maintenance, Social Facilitation Maintenance; Behavioral
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 7 Years to 12 Years
Enrollment: 216 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2004
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Obstructive Sleep Apnea, Pregnancy, Obesity, Sleep
Interventions: Not listed
Lead sponsor: The Miriam Hospital; Other
Eligibility: 18 Years and older · Female only
Enrollment: 450 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2025
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Nausea
Interventions: SeaBand; Device
Lead sponsor: Florencia Ziemke; Other
Eligibility: 18 Years to 90 Years
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Jupiter, Florida

Conditions: Obesity
Interventions: TV modification, safety and injury prevention; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 2 Years to 5 Years
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Cancer, Breast, Obesity, Abdominal
Interventions: SCOPE-Chinese Women; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older · Female only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Morbid Obesity
Interventions: Laparscopic Sleeve Gastrectomy, Weight Watchers Program; Procedure · Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 65 Years · Female only
Healthy volunteers: Accepts healthy volunteers
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Overweight, Obesity
Interventions: Eloralintide, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older
Enrollment: 900 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 58
States / cities: Birmingham, Alabama • Phoenix, Arizona • Scottsdale, Arizona + 51 more

Conditions: Obesity
Interventions: Nutrition facts automatically or not automatically displayed, Nutrition facts in color, Nutrition Facts Label in Larger Font, Healthier Items First; Behavioral
Lead sponsor: University of Vermont; Other
Eligibility: Not listed
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Impulsivity, Compulsive Overeating, Obesity
Interventions: Device: Active Transcranial Direct Current Stimulation (tDCS) coupled with cognitive training, Device: Sham Transcranial Direct Current Stimulation (tDCS) coupled with cognitive training; Device
Lead sponsor: Minneapolis Veterans Affairs Medical Center; Federal
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Schizophrenia, Chronic Illness, Weight Gain, Psychotic Disorder
Interventions: Collaborative Chronic Illness Care Model; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 1,067 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 8
States / cities: Long Beach, California • West Los Angeles, California • Shreveport, Louisiana + 5 more

Conditions: Obesity
Interventions: Sandostatin LAR; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 6 Years to 18 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2004
U.S. locations: 15
States / cities: Phoenix, Arizona • Orange, California • San Francisco, California + 12 more

Search by objective public record fields.

Interplay of Central and Peripheral Vascular Effects of Insulin in Obesity

The Effects of Obesity and Obstructive Sleep Apnea on Inflammation and Heart Disease

Neck Fat Accumulation and Its Relationship to Cardiovascular Risk and Metabolic Syndrome

Circadian Timing, Information Processing and Energy Balance Study

The Effect Of NS-0200 and NS-0300 Versus Placebo on Weight In Obesity

Bariatric Surgery-Induced Shift in Gut Microbiome and NAFLD

Healthy Juntos Pilot Study

Parents As The Agent Of Change For Childhood Obesity (PAAC)

Vitamin D, Diet and Activity Study

ER Stress in NAFLD

Mat Pilates and Vascular Function in Obese Females

Growing Healthy Children and Families in Rural Arkansas

Substituting Mushrooms for Meat to Control Body Weight

Childhood Obesity Treatment: A Maintenance Approach

Predictors of De-novo Development of Obstructive Sleep Apnea in Pregnancy

Acupressure Wristbands for GLP-1RA Related Nausea

Starting Healthy Staying Healthy Pilot Trial

SCOPE-Chinese Women Study

Laparoscopic Sleeve Gastrectomy Plus Weight Watchers vs. Weight Watchers Alone in Underserved Minority Women

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Promoting Healthier Food Purchases By Leveraging the Online-Grocery Environment

tDCS for Impulsivity and Compulsivity in Obesity

Implementing Effective, Collaborative Care for Schizophrenia (EQUIP-2)

Pediatric Hypothalamic Obesity